You are here:
NICE
NICE Guidance
Conditions and diseases
Cardiovascular conditions
Embolism and thrombosis
Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults
Technology appraisal guidance
Reference number:
TA170
Published:
22 April 2009
Guidance
Tools and resources
Information for the public
History
Research recommendations coming out of this guidance
There are no research recommendations for TA170